Keep an eye on beaten-down shares of Asana (ASAN). CEO Dustin Moskovitz recently purchased an additional 225,000 shares on July 8. He paid an average cost of $14.60 per share, totaling $3,285,000. He also picked up about $6.86 million worth of...
Just last week, we highlighted an opportunity in Viking Therapeutics (VKTX). At the time, it traded at about $26.50 as it initiated its VANQUISH Phase 3 clinical program for VK2735, the company’s dual agonist of the glucagon-like peptide 1 (GLP-1) and...
by Ian Cooper Always keep an eye on stock splits. While splits don’t change the value of a stock, they can serve as a positive signal. This can then lead to further liquidity and more investor interest. After all, if an attractive $500 stock were to split 10:1,...
Keep an eye on Amazon (AMZN). Since 2016, every time there’s been a golden cross (50-day moving average jumps above the 200-day moving average), the stock has turned even higher. Around the start of April 2016, a golden cross appeared before the stock ran from about...
We’re sitting ducks. After all these years, we’re still not ready for cyberattacks. Our own government isn’t ready for more. Most recently, “the US Coast Guard has been urged to improve the cybersecurity infrastructure of the Maritime Transportation System (MTS),...
With a yield of 5.2%, Bristol-Myers Squibb (BMY) is an undervalued biopharmaceutical company that discovers, develops, licenses and sells drugs around the world for use in oncology, hematology, immunology, cardiovascular, neuroscience, to name just a few. It’s also...
Bitcoin is just starting to accelerate higher again. At the start of 2024, the digital currency traded at $42,280. Today, it’s up to $107,869 and could run even higher on retail, government, and institutional interest. Helping, the U.S. Senate just passed a landmark...
by Ian Cooper Bitcoin is just starting to accelerate higher again. At the start of 2024, the digital currency traded at $42,280. Today, it’s up to $107,338 and could run even higher on retail, government, and institutional interest. Helping, the U.S. Senate just...
It’s time to jump back into Viking Therapeutics (VKTX). Now trading at $26.50, VKTX could explode higher again. That is, if the company sees further positive results with its obesity trials. Most recently, VKTX initiated its VANQUISH Phase 3 clinical program for...
With markets still volatile, it’s a good idea to keep your portfolio protected. One of the best ways to do just that is by investing in safe, high-yielding stocks and exchange-traded funds (ETFs). According to Franklin Templeton: “While at times overlooked,...